Brief introduction of BenQ Material Co., Ltd.

BenQ Materials Co., Ltd. was formally established in Suzhou Industrial Park at the end of 2003 with a registered capital of 30 million US dollars, covering an area of 200 mu. Has the most advanced production equipment and manufacturing technology in the same industry in the world, mainly engaged in the research and development and manufacturing of polarizing films. Our goal is to provide the most competitive "electronic chemistry" products and become the most respected enterprise. With professional technology and rapid mass production capacity in photoelectric materials, it ranks fourth in the world and the largest polarizer manufacturer in China, and has become an important part of the development strategy of "BenQ AUO Group" with LCD as the core.

At present, there are 3,000 employees, of whom 10% are management R&D personnel with a master's degree or above, and 86% have a bachelor's degree, with an average age of 27. Under the guidance of market demand, the company is becoming more and more mature, with a lean and efficient team of professional managers and excellent employees with various professional skills, which ensures the company's sustainable competitiveness.

Marsh Medical Technology (Suzhou) Co., Ltd. was established in Suzhou Industrial Park in 2009. As the marketing headquarters of BenQ Materials in Chinese mainland, our original intention is to introduce the concept of high quality and low cost in the electronics industry into the development and production of medical products. We are determined to innovate medical products and provide customers with high-quality products and services efficiently. Based on the R&D headquarters in Taoyuan, Taiwan Province, and with the clinical verification of BenQ Hospital (Nanjing, 3A Teaching Hospital), we launched a series of "Advanced Wound Dressing" nursing products, which are committed to expanding from wound management to skin care, from first-class and second-class products to third-class products, and continue to provide medical products with more cost competitive advantages for the benefit of medical institutions and patients.